Nephrostomy Devices Market Report and Forecast 2024-2032

Global Nephrostomy Devices Market Report and Forecast 2024-2032


The global nephrostomy devices market reached a value of approximately USD 1.36 billion in 2023. The market is anticipated to grow at a robust CAGR of 8.5% during the forecast period of 2024-2032. The market is likely to reach a value of USD 2.83 billion by 2032. This growth is expected to be driven by increasing incidence of urological conditions, rising demand in the healthcare sector, advancements in medical technology, and increased awareness of urological health solutions.



Global Nephrostomy Devices Market- Analysis

Nephrostomy devices are essential medical tools used for draining urine from a blocked kidney. These devices are typically employed in cases where there is an obstruction in the urinary tract, often due to kidney stones, tumours, or other urological conditions. The global market for nephrostomy devices is expanding, driven by the increasing prevalence of urological diseases, the growing ageing population, and the rising adoption of minimally invasive surgical procedures. As healthcare providers and patients seek more efficient and less invasive treatment options, the demand for advanced nephrostomy devices is expected to rise significantly.

Market Drivers

Rising Prevalence of Urological Disorders: The increasing incidence of urological conditions, such as kidney stones, tumours, and other urinary obstructions, is a major driver of the nephrostomy devices market. As these conditions become more common, the demand for nephrostomy procedures and associated devices continues to grow.

Advancements in Medical Technology: Continuous advancements in medical technology are improving the effectiveness and safety of nephrostomy devices. Innovations in device materials, design, and imaging technologies are enhancing patient outcomes, thereby driving market growth.

Growing Ageing Population: The global ageing population is more prone to urological issues, including kidney-related disorders. As the elderly population increases, so does the demand for nephrostomy procedures, contributing to the expansion of the market.

Increasing Adoption of Minimally Invasive Procedures: There is a growing preference for minimally invasive procedures among healthcare providers and patients. Nephrostomy devices, which are integral to these procedures, are seeing increased adoption due to their ability to reduce recovery times, minimise complications, and improve patient comfort.

Favourable Reimbursement Policies: Supportive reimbursement policies in key markets are encouraging the use of nephrostomy devices. These policies reduce the financial burden on patients, making advanced urological treatments more accessible and driving the market forward.

Market Challenges

Risk of Complications: Nephrostomy procedures, while generally safe, carry risks of complications such as infections, bleeding, and device malfunctions. These potential risks can hinder the widespread adoption of nephrostomy devices, particularly among risk-averse patients and healthcare providers.

Limited Availability of Skilled Professionals: The successful implementation of nephrostomy procedures requires skilled healthcare professionals. In regions where there is a shortage of trained personnel, the adoption of these devices may be limited, thereby restraining market growth.

Stringent Regulatory Requirements: Navigating the complex regulatory landscape for nephrostomy devices can be challenging for manufacturers. Meeting stringent regulatory standards and obtaining approvals can delay the market entry of new devices, impacting overall market growth.

Patient Awareness and Acceptance: Limited awareness and acceptance of nephrostomy procedures among patients can be a challenge. Educating patients about the benefits and safety of these procedures is essential for increasing adoption rates and market penetration.

Future Opportunities

Development of Cost-Effective Devices: There is an opportunity for manufacturers to develop cost-effective nephrostomy devices that cater to the needs of low- and middle-income regions. Affordable devices can expand market reach and improve accessibility to advanced urological care.

Integration with Advanced Imaging Technologies: The integration of nephrostomy devices with advanced imaging technologies, such as ultrasound and MRI, offers significant growth opportunities. These integrated solutions can enhance the accuracy and safety of nephrostomy procedures, driving market adoption.

Collaborations and Partnerships: Collaborations between device manufacturers, research institutions, and healthcare providers can lead to the development of innovative nephrostomy solutions. These partnerships can accelerate product development and market entry, driving growth in the industry.

Focus on Patient-Centric Designs: There is a growing demand for nephrostomy devices that are designed with patient comfort and ease of use in mind. Manufacturers that focus on developing user-friendly devices that enhance patient experience are likely to gain a competitive advantage in the market.

Global Nephrostomy Devices Market Trends

Adoption of Biocompatible Materials: There is an increasing trend towards the use of biocompatible materials in the manufacture of nephrostomy devices. These materials reduce the risk of adverse reactions and improve patient outcomes, making them more appealing to healthcare providers and patients alike.

Growth in Home Care Settings: The growing preference for home care settings for post-operative recovery is influencing the demand for portable and easy-to-use nephrostomy devices. This trend is driving innovation in device design, with manufacturers focusing on developing products suitable for home use.

Focus on Infection Control: Infection control is a critical concern in nephrostomy procedures. There is a rising trend towards the development of devices with antimicrobial properties to reduce the risk of infections, thereby improving patient safety and outcomes.

Technological Advancements in Drainage Systems: Technological advancements in nephrostomy drainage systems are enhancing the efficiency and safety of these devices. Innovations such as closed drainage systems and self-flushing mechanisms are gaining popularity, reflecting a shift towards more advanced and reliable solutions.

Increased Use of Disposable Devices: The trend towards disposable nephrostomy devices is gaining traction, particularly in hospitals and clinics. Disposable devices reduce the risk of cross-contamination and simplify the logistics of sterilisation, making them a preferred choice in many healthcare settings.

Global Nephrostomy Devices Market Segmentation

Market Breakup by Product

Percutaneous Nephrostomy Devices

Nephrostomy Drainage Bags

Nephrostomy Kits

Accessories and Consumables

The nephrostomy devices market is segmented by product type, including percutaneous nephrostomy devices, nephrostomy drainage bags, nephrostomy kits, and accessories and consumables. Percutaneous nephrostomy devices, used for direct access to the kidney, are essential in treating obstructive uropathy. Nephrostomy drainage bags are critical in managing urine flow post-procedure, while nephrostomy kits provide all the necessary tools for the procedure. Accessories and consumables, including catheters and connectors, support the ongoing use and maintenance of nephrostomy systems.

Market Breakup by Product Material

Silicone

Polyurethane

Others

The market is further segmented by product material, encompassing silicone, polyurethane, and other materials. Silicone is widely used for its biocompatibility and flexibility, making it suitable for long-term use in nephrostomy devices. Polyurethane offers strength and durability, often used in more robust applications. Other materials include advanced polymers that combine the benefits of both silicone and polyurethane, catering to specific patient needs.

Market Breakup by Procedure Type

Diagnostic Nephrostomy

Therapeutic Nephrostomy

Emergency Nephrostomy

The market is categorised by procedure type into diagnostic nephrostomy, therapeutic nephrostomy, and emergency nephrostomy. Diagnostic nephrostomy is used to assess kidney function and detect blockages, while therapeutic nephrostomy is a treatment approach for conditions like hydronephrosis. Emergency nephrostomy is performed in critical situations to relieve acute urinary obstruction, highlighting the importance of nephrostomy devices in diverse clinical scenarios.

Market Breakup by End User

Hospitals and Clinics

Home Care Settings

Others

The market is segmented by end user into hospitals and clinics, home care settings, and others. Hospitals and clinics are the primary users of nephrostomy devices, given the need for specialised care and monitoring during and after the procedure. Home care settings are increasingly adopting portable nephrostomy devices, driven by the trend towards home-based recovery and patient preference for non-hospital environments. Other end users include specialised urology centres and research institutions.

Market Breakup by Region

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

Regionally, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America leads the market due to advanced healthcare infrastructure and high prevalence of urological conditions. Europe follows closely, with strong healthcare systems and growing adoption of minimally invasive procedures. The Asia Pacific region is expected to witness significant growth, driven by increasing healthcare access and rising awareness of urological health. Latin America the Middle East and Africa are emerging markets with growing demand for nephrostomy devices as healthcare infrastructure develops.

Global Nephrostomy Devices Market Competitive Landscape

The global nephrostomy devices market features key players such as Boston Scientific Corporation, Cook Medical Inc., Uresil LLC, Teleflex, Inc., Coloplast Corporation, Argon Medical Devices, Inc., Becton, Dickinson, and Company, Olympus Corporation, B. Braun SE, Cardinal Health, Inc. These companies are at the forefront of innovation, focusing on the development of advanced nephrostomy devices that improve patient outcomes and streamline procedures. By leveraging cutting-edge technology and addressing the needs of healthcare providers, these market leaders are driving growth and setting new standards in the nephrostomy devices industry.

Key Questions Answered in the Report

What are the primary factors driving the demand for nephrostomy devices in the healthcare industry?

What challenges do manufacturers face in the nephrostomy devices market, and how are they addressing them?

How are advancements in medical technology influencing the development of nephrostomy devices?

What are the emerging trends in the nephrostomy devices market that are expected to shape its future?

How does patient preference for minimally invasive procedures impact the demand for nephrostomy devices?

In what ways are regulatory policies affecting the adoption and innovation of nephrostomy devices globally?

What role do nephrostomy drainage bags play in the overall market, and how is their demand evolving?

How are silicone and polyurethane materials contributing to the performance of nephrostomy devices?

Why is the Asia Pacific region expected to see significant growth in the nephrostomy devices market?

How are hospitals and clinics driving the demand for nephrostomy devices compared to home care settings?

What competitive strategies are key players in the nephrostomy devices market employing to strengthen their market position?

Key Benefits for Stakeholders

The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the global nephrostomy devices market from 201724-2032.

The research report provides the latest information on the market drivers, challenges, and opportunities in the global nephrostomy devices market.

The study maps the leading, as well as the fastest-growing, regional markets, enabling stakeholders to identify key country-level markets within each region.

Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders analyse the level of competition within the global nephrostomy devices industry and its attractiveness.

The competitive landscape section allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market. *Please Note:* The report will take 7 business days to complete, after order confirmation.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Nephrostomy Devices Market Overview
3.1 Global Nephrostomy Devices Market Historical Value (2017-2023)
3.2 Global Nephrostomy Devices Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Nephrostomy Devices Market Landscape*
5.1 Global Nephrostomy Devices Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Nephrostomy Devices Market: Product Landscape
5.2.1 Analysis by Product
6 Global Nephrostomy Devices Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Nephrostomy Devices Market: Trade Data Analysis (HS Code: 90189030)
7.1 Major Exporting Countries
7.1.1 By Value
7.1.2 By Volume
7.2 Major Importing Countries
7.2.1 By Value
7.2.2 By Volume
8 Global Nephrostomy Devices Market Segmentation (2017-2032)
8.1 Global Nephrostomy Devices Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Percutaneous Nephrostomy Devices
8.1.3 Nephrostomy Drainage Bags
8.1.4 Nephrostomy Kits
8.1.5 Accessories and Consumables
8.2 Global Nephrostomy Devices Market (2017-2032) by Product Material
8.2.1 Market Overview
8.2.2 Silicone
8.2.3 Polyurethane
8.2.4 Others
8.3 Global Nephrostomy Devices Market (2017-2032) by Procedure Type
8.3.1 Market Overview
8.3.2 Diagnostic Nephrostomy
8.3.3 Therapeutic Nephrostomy
8.3.4 Emergency Nephrostomy
8.4 Global Nephrostomy Devices Market (2017-2032) by End User
8.4.1 Market Overview
8.4.2 Hospitals and Clinics
8.4.3 Home Care Settings
8.4.4 Others
8.5 Global Nephrostomy Devices Market (2017-2032) by Region
8.5.1 Market Overview
8.5.2 North America
8.5.3 Europe
8.5.4 Asia Pacific
8.5.5 Latin America
8.5.6 Middle East and Africa
9 North America Nephrostomy Devices Market (2017-2032)
9.1 North America Nephrostomy Devices Market (2017-2032) Product
9.1.1 Market Overview
9.1.2 Percutaneous Nephrostomy Devices
9.1.3 Nephrostomy Drainage Bags
9.1.4 Nephrostomy Kits
9.1.5 Accessories and Consumables
9.2 North America Nephrostomy Devices Market (2017-2032) by Product Material
9.2.1 Market Overview
9.2.2 Silicone
9.2.3 Polyurethane
9.2.4 Others
9.3 North America Nephrostomy Devices Market (2017-2032) by Procedure Type
9.3.1 Market Overview
9.3.2 Diagnostic Nephrostomy
9.3.3 Therapeutic Nephrostomy
9.3.4 Emergency Nephrostomy
9.4 North America Nephrostomy Devices Market (2017-2032) by End User
9.4.1 Market Overview
9.4.2 Hospitals and Clinics
9.4.3 Home Care Settings
9.4.4 Others
9.5 North America Nephrostomy Devices Market (2017-2032) by Country
9.5.1 United States of America
9.5.2 Canada
10 Europe Nephrostomy Devices Market (2017-2032)
10.1 Europe Nephrostomy Devices Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Percutaneous Nephrostomy Devices
10.1.3 Nephrostomy Drainage Bags
10.1.4 Nephrostomy Kits
10.1.5 Accessories and Consumables
10.2 Europe Nephrostomy Devices Market (2017-2032) by Product Material
10.2.1 Market Overview
10.2.2 Silicone
10.2.3 Polyurethane
10.2.4 Others
10.3 Europe Nephrostomy Devices Market (2017-2032) by Procedure Type
10.3.1 Market Overview
10.3.2 Diagnostic Nephrostomy
10.3.3 Therapeutic Nephrostomy
10.3.4 Emergency Nephrostomy
10.4 Europe Nephrostomy Devices Market (2017-2032) by End User
10.4.1 Market Overview
10.4.2 Hospitals and Clinics
10.4.3 Home Care Settings
10.4.4 Others
10.5 Europe Nephrostomy Devices Market (2017-2032) by Country
10.5.1 United Kingdom
10.5.2 Germany
10.5.3 France
10.5.4 Italy
10.5.5 Others
11 Asia Pacific Nephrostomy Devices Market (2017-2032)
11.1 Asia Pacific Nephrostomy Devices Market (2017-2032) by Product
11.1.1 Market Overview
11.1.2 Percutaneous Nephrostomy Devices
11.1.3 Nephrostomy Drainage Bags
11.1.4 Nephrostomy Kits
11.1.5 Accessories and Consumables
11.2 Asia Pacific Nephrostomy Devices Market (2017-2032) by Product Material
11.2.1 Market Overview
11.2.2 Silicone
11.2.3 Polyurethane
11.2.4 Others
11.3 Asia Pacific Nephrostomy Devices Market (2017-2032) by Procedure Type
11.3.1 Market Overview
11.3.2 Diagnostic Nephrostomy
11.3.3 Therapeutic Nephrostomy
11.3.4 Emergency Nephrostomy
11.4 Asia Pacific Nephrostomy Devices Market (2017-2032) by End User
11.4.1 Market Overview
11.4.2 Hospitals and Clinics
11.4.3 Home Care Settings
11.4.4 Others
11.5 Asia Pacific Nephrostomy Devices Market (2017-2032) by Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4 ASEAN
11.5.5 Australia
11.5.6 Others
12 Latin America Nephrostomy Devices Market (2017-2032)
12.1 Latin America Nephrostomy Devices Market (2017-2032) by Product
12.1.1 Market Overview
12.1.2 Percutaneous Nephrostomy Devices
12.1.3 Nephrostomy Drainage Bags
12.1.4 Nephrostomy Kits
12.1.5 Accessories and Consumables
12.2 Latin America Nephrostomy Devices Market (2017-2032) by Product Material
12.2.1 Market Overview
12.2.2 Silicone
12.2.3 Polyurethane
12.2.4 Others
12.3 Latin America Nephrostomy Devices Market (2017-2032) by Procedure Type
12.3.1 Market Overview
12.3.2 Diagnostic Nephrostomy
12.3.3 Therapeutic Nephrostomy
12.3.4 Emergency Nephrostomy
12.4 Latin America Nephrostomy Devices Market (2017-2032) by End User
12.4.1 Market Overview
12.4.2 Hospitals and Clinics
12.4.3 Home Care Settings
12.4.4 Others
12.5 Latin America Nephrostomy Devices Market (2017-2032) by Country
12.5.1 Brazil
12.5.2 Argentina
12.5.3 Mexico
12.5.4 Others
13 Middle East and Africa Nephrostomy Devices Market (2017-2032)
13.1 Middle East and Africa Nephrostomy Devices Market (2017-2032) by Product
13.1.1 Market Overview
13.1.2 Percutaneous Nephrostomy Devices
13.1.3 Nephrostomy Drainage Bags
13.1.4 Nephrostomy Kits
13.1.5 Accessories and Consumables
13.2 Middle East and Africa Nephrostomy Devices Market (2017-2032) by Product Material
13.2.1 Market Overview
13.2.2 Silicone
13.2.3 Polyurethane
13.2.4 Others
13.3 Middle East and Africa Nephrostomy Devices Market (2017-2032) by Procedure Type
13.3.1 Market Overview
13.3.2 Diagnostic Nephrostomy
13.3.3 Therapeutic Nephrostomy
13.3.4 Emergency Nephrostomy
13.4 Middle East and Africa Nephrostomy Devices Market (2017-2032) by End User
13.4.1 Market Overview
13.4.2 Hospitals and Clinics
13.4.3 Home Care Settings
13.4.4 Others
13.5 Middle East and Africa Nephrostomy Devices Market (2017-2032) by Country
13.5.1 Saudi Arabia
13.5.2 United Arab Emirates
13.5.3 Nigeria
13.5.4 South Africa
13.5.5 Others
14 Regulatory Framework
14.1 Regulatory Overview
14.2 US FDA
14.3 EU EMA
14.4 INDIA CDSCO
14.5 JAPAN PMDA
14.6 Others
15 Patent Analysis
15.1 Analysis by Type of Patent
15.2 Analysis by Publication Year
15.3 Analysis by Issuing Authority
15.4 Analysis by Patent Age
15.5 Analysis by CPC Analysis
15.6 Analysis by Patent Valuation
15.7 Analysis by Key Players
16 Grants Analysis
16.1 Analysis by Year
16.2 Analysis by Amount Awarded
16.3 Analysis by Issuing Authority
16.4 Analysis by Grant Application
16.5 Analysis by Funding Institute
16.6 Analysis by NIH Departments
16.7 Analysis by Recipient Organization
17 Funding and Investment Analysis
17.1 Analysis by Funding Instances
17.2 Analysis by Type of Funding
17.3 Analysis by Funding Amount
17.4 Analysis by Leading Players
17.5 Analysis by Leading Investors
17.6 Analysis by Geography
18 Strategic Initiatives
18.1 Analysis by Partnership Instances
18.2 Analysis by Type of Partnership and Collaborations
18.3 Analysis by Joint Ventures
18.4 Analysis by Leading Players
18.5 Analysis by Geography
19 Supplier Landscape
19.1 Market Share Analysis, By Region (Top 5 Companies)
19.1.1 Market Share Analysis: Global
19.1.2 Market Share Analysis: North America
19.1.3 Market Share Analysis: Europe
19.1.4 Market Share Analysis: Asia Pacific
19.1.5 Market Share Analysis: Others
19.2 Boston Scientific Corporation
19.2.1 Financial Analysis
19.2.2 Product Portfolio
19.2.3 Demographic Reach and Achievements
19.2.4 Company News and Development
19.2.5 Certifications
19.3 Cook Medical Inc .
19.3.1 Financial Analysis
19.3.2 Product Portfolio
19.3.3 Demographic Reach and Achievements
19.3.4 Company News and Development
19.3.5 Certifications
19.4 Uresil LLC
19.4.1 Financial Analysis
19.4.2 Product Portfolio
19.4.3 Demographic Reach and Achievements
19.4.4 Company News and Development
19.4.5 Certifications
19.5 Teleflex, Inc .
19.5.1 Financial Analysis
19.5.2 Product Portfolio
19.5.3 Demographic Reach and Achievements
19.5.4 Company News and Development
19.5.5 Certifications
19.6 Coloplast Corporation
19.6.1 Financial Analysis
19.6.2 Product Portfolio
19.6.3 Demographic Reach and Achievements
19.6.4 Company News and Development
19.6.5 Certifications
19.7 Argon Medical Devices , Inc.
19.7.1 Financial Analysis
19.7.2 Product Portfolio
19.7.3 Demographic Reach and Achievements
19.7.4 Company News and Development
19.7.5 Certifications
19.8 Becton, Dickinson, and Company
19.8.1 Financial Analysis
19.8.2 Product Portfolio
19.8.3 Demographic Reach and Achievements
19.8.4 Company News and Development
19.8.5 Certifications
19.9 Olympus Corporation
19.9.1 Financial Analysis
19.9.2 Product Portfolio
19.9.3 Demographic Reach and Achievements
19.9.4 Company News and Development
19.9.5 Certifications
19.10 B. Braun SE
19.10.1 Financial Analysis
19.10.2 Product Portfolio
19.10.3 Demographic Reach and Achievements
19.10.4 Company News and Development
19.10.5 Certifications
19.11 Cardinal Health, Inc .
19.11.1 Financial Analysis
19.11.2 Product Portfolio
19.11.3 Demographic Reach and Achievements
19.11.4 Company News and Development
19.11.5 Certifications
20 Global Nephrostomy Devices Market – Distribution Model (Additional Insight)
20.1 Overview
20.2 Potential Distributors
20.3 Key Parameters for Distribution Partner Assessment
21 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings